Manufacturing and Nonclinical Studies Support for the Development of Therapeutic... Tender

Procurement Summary

Country : USA

Summary : Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological Related Disorders

Deadline : 15 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 98808644

Document Ref. No. : 75N95024R00050

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Purchaser : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contracting Office Address : Bethesda, MD 20892
Primary Point of Contact : Kimberly Espinosa
kimberly.espinosa@nih.gov

USA
Email :kimberly.espinosa@nih.gov

Tender Details

Description

Amendment 1: A Question and Response document is posted and the anticipated RFP issue date is postponed to on or after April 15, 2024.

INTRODUCTION

PURSUANT TO FAR Subpart 5.2 - Synopses of Proposed Contract Actions, THIS IS A PRE-SOLICITATION NOTICE OF A PROPOSED CONTRACT ACTION.

The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institutes of Neurological Disorders and Stroke (NINDS), intends to award one or more Indefinite Delivery / Indefinite Quantity (IDIQ) contracts for Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological-related Disorders. It is anticipated that the IDIQ award(s) will be made in the first quarter of Fiscal Year 2025 and will allow for the issuance of fixed-price and cost-reimbursement type task orders.

A Request for Proposals (RFP) Number 75N95024R00050, entitled: “Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological-related Disorders" is anticipated to be issued on SAM.gov on or after April 15, 2024.

PLEASE NOTE: This solicitation is a Ramp-On re-opening and re-soliciting of Request for Proposals (RFP) No. 75N95022R00013 that was issued on January 25, 2022, with the purpose of adding one or more contractors to the existing Indefinite Delivery / Indefinite Quantity (IDIQ) contract pool supporting this program. The ordering period of the IDIQ contracts expire on September 29, 2030 and any new awards made under RFP No. 75N95024R00050 will have an ordering period that expires on September 29, 2030.

DESCRIPTION OF REQUIREMENT

The National Institutes of Neurological Disorders and Stroke (NINDS) has a need for current Good Manufacturing Practices (cGMP) manufacturing and Good Laboratory Practice (GLP) nonclinical (preclinical) support services to support translational development of therapeutic bio...
Active Contract Opportunity Notice ID 75N95024R00050 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIDA
General Information
Contract Opportunity Type: Presolicitation (Updated)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Updated Published Date: Mar 13, 2024 03:07 pm EDT
Original Published Date: Feb 28, 2024 11:58 am EST
Updated Response Date: Apr 15, 2024 03:00 pm EDT
Original Response Date: Mar 14, 2024 03:00 pm EDT
Inactive Policy: 15 days after response date
Updated Inactive Date: Apr 30, 2024
Original Inactive Date: Mar 29, 2024
Initiative: None

Classification
Original Set Aside:

Product Service Code: AN12 - Health R&D Services; Health care services; Applied Research
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance:

Documents

 Tender Notice

75N95024R00050_Presolicitation-QandA.pdf